Assistant Professor at Linköping University | Trained at the Icahn School of Medicine at Mount Sinai, New York
Cancer Immunology | Immunotherapy | OncolyticVirotherapy | TME | DCs | Lymphoma
https://liu.se/en/research/tumor-immunology-and-immunotherapy
Judit Svensson Arvelund
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - @mitkochinstitute.bsky.social go.nature.com/42td2fh
Reminder for the 51st Annual Meeting of the Scandinavian Society for Immunology!
The meeting will take place September 7-10, 2026 in Bergen and includes a summer school program
Early bird registration & abstract submission deadline: June 1st
For full program and to register: www.ssi2026.no
Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.
Very cool paper in @cp-immunity.bsky.social showing that a "dietary modulation of NKT-XCL1-cDC1 axis in combination with immune check points inhibitors may open avenues for improved treatments of colon cancer".👇
www.sciencedirect.com/science/arti...
Nature Biotechnology
Marco et al. sought to expand the utility of immunizing radiation (IR) therapy by intratumorally delivering agents to remodel the tumor immune microenvironment (TIME). bit.ly/4t8ud0W
Chronic inflammation has long been linked to cancer, but how is that history retained in the tissue?
In a new #Nature study, Nagaraja et al show that colitis leaves a lasting epigenetic memory in colonic stem cells, which persists after inflammation resolves & primes for subsequent tumor growth 🧪🔬
New piece on the decision of #ERC to reverse their stricter rules after the community came together to voice our opinions - a great example of the power of collective action!
Very happy to have been part of this - and to see how we can now build on this momentum 🙌
www.nature.com/articles/d41... 🧪
Excited to share recent work from our lab in @bloodjournal.bsky.social #BloodAdvances! We studied the impact of CD45-targeted radioimmunotherapy (RIT) on the bone marrow vascular niche. Turns out the vasculature is majorly disrupted by hematopoietic targeted RIT ☢️🩸
shorturl.at/qzWIB
The efficacy of immune checkpoint inhibitors (ICIs) in colon cancer (CC) is limited by the tolerogenic immune landscape of both the tumor and the inte…
Thanks @the-node.bsky.social @biologists.bsky.social for allowing spreading the word
@kawresearch.bsky.social @scilifelab.se @remeseiro-lab.bsky.social
thenode.biologists.com/join-the-sum...
The French DC Society - Club Francophone des DC (CFCD)
The tough new policy was introduced to curb submissions, but drew criticism from researchers.
📢 Tune in to this week's episode!
Dr. Alfred Singer at the National Cancer Institute Center for Cancer Research discusses his pioneering work on thymus development and T cell differentiation, including how T cells are selected to become CD4 helper or CD8 cytotoxic cells.
🎧 https://bit.ly/4f2ci85
The School will be a 4-day (23-26 June 2026) Theory&Computation course in a splendid Swedish inland Resort (2 hours away from Stockholm - our bus will
Chronic inflammation increases the risk of colon cancer. This inflammation drives epigenetic changes in the nucleus of stem cells that promote tumour formation.